Follow
Dominique Geoffrion MD CM PhD
Dominique Geoffrion MD CM PhD
Ophthalmology, Université de Montréal
Verified email at mail.mcgill.ca
Title
Cited by
Cited by
Year
High-throughput screening in niche-based assay identifies compounds to target preleukemic stem cells
B Gerby, DFT Veiga, J Krosl, S Nourreddine, J Ouellette, A Haman, ...
The Journal of Clinical Investigation 126 (12), 4569-4584, 2016
392016
Multiple DICER1‐related tumors in a child with a large interstitial 14q32 deletion
L de Kock, D Geoffrion, B Rivera, R Wagener, N Sabbaghian, S Bens, ...
Genes, Chromosomes and Cancer 57 (5), 223-230, 2018
372018
Glaucoma risk factors and outcomes following Boston keratoprosthesis type 1 surgery
D Geoffrion, M Harissi-Dagher
American Journal of Ophthalmology 226, 56-67, 2021
182021
Apoptotic blocks in primary non-Hodgkin B cell lymphomas identified by BH3 profiling
RN Rys, CM Wever, D Geoffrion, C Goncalves, A Ghassemian, ...
Cancers 13 (5), 1002, 2021
112021
Tear film cytokine profile of patients with the Boston keratoprosthesis type 1: comparing patients with and without glaucoma
D Geoffrion, MC Robert, A Di Polo, RK Koenekoop, Y Agoumi, ...
Investigative Ophthalmology & Visual Science 62 (4), 20-20, 2021
82021
Assessment of the role and timing of glaucoma surgery in Boston keratoprosthesis type 1 patients
D Geoffrion, SI Hassanaly, M Marchand, R Daoud, Y Agoumi, ...
American Journal of Ophthalmology 235, 249-257, 2022
72022
The genomic landscape of two Burkitt lymphoma cases and derived cell lines: Comparison between primary and relapse samples
CM Wever, D Geoffrion, BM Grande, S Yu, M Alcaide, M Lemaire, ...
Leukemia & lymphoma 59 (9), 2159-2174, 2018
72018
Improving glaucoma management for the Boston keratoprosthesis type 1: tubes versus lasers
D Geoffrion, M Harissi-Dagher
Expert Review of Ophthalmology 15 (6), 313-320, 2020
62020
Tisagenlecleucel in Diffuse Large B-Cell Lymphoma.
D Geoffrion, H Whittaker
The New England journal of medicine 380 (16), 1585-1585, 2019
42019
Perspectives for preclinical mouse models of glaucoma after Boston keratoprosthesis type 1
D Geoffrion, MC Robert, J Chodosh, A Di Polo, M Harissi-Dagher
Experimental Eye Research 208, 108615, 2021
22021
Probing mechanisms and improving management of glaucoma following Boston keratoprosthesis surgery
D Geoffrion, RK Koenekoop, M Harissi‐Dagher
Acta Ophthalmologica 100, 3-17, 2022
12022
Visual Field Characteristics of Type I Boston Keratoprosthesis Patients Without Glaucoma
D Geoffrion, M Harissi-Dagher
Journal of Glaucoma 30 (3), e124-e125, 2021
12021
Glaucoma outcomes following boston keratoprosthesis type 1 surgery
D Geoffrion, M Harissi-Dagher
Investigative Ophthalmology & Visual Science 61 (7), 3577-3577, 2020
12020
Bilateral conjunctival melanosis in diffuse melanosis cutis and metastatic melanoma
D Geoffrion, GA Mullie, M Harissi-Dagher
Canadian Journal of Ophthalmology 59 (2), e175, 2024
2024
Foveal Development and Posterior Precortical Vitreous Pocket Formation
D Geoffrion, S Melki, M Harissi-Dagher
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES 43 (5), E30-E31, 2023
2023
Correspondence
D Geoffrion, S Melki, M Harissi-Dagher
RETINA 43 (5), e30-e31, 2023
2023
Endoscopy-assisted total pars plana vitrectomy during Boston keratoprosthesis type 1
D Geoffrion, GA Mullie, N Arej, MA Rhéaume, M Harissi-Dagher
Canadian Journal of Ophthalmology, 2023
2023
Feasibility of a Mouse Model of Glaucoma after Boston Keratoprosthesis
D Geoffrion, MC Robert, J Chodosh, A Di Polo, M Harissi-Dagher
Cornea Open 1 (1), e0003, 2022
2022
Letter to the Editor on ‘Retinal Detachment in Eyes with Boston Type 1 Keratoprosthesis’
D Geoffrion, S Melki, M Harissi-Dagher
Retina, 2022
2022
Letter to the Editor on Corneal Sarcoidosis: Diffuse Stromal Granulomatous Inflammation in a Patient With Sarcoidosis
D Geoffrion, M Harissi-Dagher
Cornea 41 (7), e16, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–20